HPTX

Hyperion Therapeutics, Inc. News Headlines

$24.6
*  
0.39
 negative 
1.61%
Get HPTX Alerts
*Delayed - data as of Apr. 15, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Wednesday Sector Leaders: Drugs, Biotechnology Stocks
4/9/2014 4:00:13 PM - BNK Invest

Hyperion To Present At Needham Conference; Webcast At 10:00 AM ET
4/8/2014 9:00:00 AM - RTT News

Hyperion Therapeutics To Present At ROTH Conference ; Webcast At 1:30 PM ET
3/11/2014 12:32:00 PM - RTT News

Hyperion Therapeutics Q4 13 Earnings Conference Call At 4:30 PM ET
2/27/2014 3:00:00 PM - RTT News

Hyperion: Glycerol Phenylbutyrate Phase 2 Trial Meets Primary Endpoint
2/25/2014 9:14:00 AM - RTT News

Hyperion Therapeutics To Present At Leerink Global Conference;Webcast At 2:40PM
2/13/2014 1:40:00 PM - RTT News

Hyperion Therapeutics (HPTX) Jumps: Stock Adds 5.2% - Tale of the Tape
12/19/2013 10:18:03 AM - Zacks.com

2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts
11/1/2013 11:48:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Higher Pre-Market; Lexicon Surges 21% on Glucose Inhibitor's Success
10/1/2013 8:02:50 AM - MT Newswires

Sector Update: Healthcare
10/1/2013 8:00:29 AM - MT Newswires

Hyperion Presents Data on Ravicti - Analyst Blog
9/5/2013 1:30:01 PM - Zacks.com

Hyperion's Loss Narrows Y/Y - Analyst Blog
8/20/2013 1:07:01 PM - Zacks.com

After-Hours Earnings Report for August 14, 2013 : CSCO, A, NTAP, SLW, NTES, CACI, VIPS, HOLI, HPTX, RENN, LWAY, AVNW
8/14/2013 2:00:07 PM - NASDAQ.com News

Data from Hyperion's UCD Drugs - Analyst Blog
6/24/2013 7:30:01 PM - Zacks.com

Hyperion Acquires Buphenyl Rights - Analyst Blog
6/10/2013 5:28:46 PM - Zacks.com

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
5/3/2013 10:18:00 PM - Seeking Alpha

5 Biotechnology Stocks That Greatly Outperformed The Market In Q1
4/15/2013 4:12:00 AM - Seeking Alpha

Best-Performing Russell 3000 Stocks Year To Date
2/11/2013 6:38:00 PM - Seeking Alpha

Market Bets On Approval For Hyperion's Ravicti On FDA's 'Hint'
1/24/2013 1:07:00 PM - Seeking Alpha

Hyperion's Drug Ravicti Likely To Receive FDA Approval
1/9/2013 11:30:00 AM - Seeking Alpha

Upcoming Orphan Drug Approval Decisions For 4 Biopharma Companies
12/20/2012 1:21:00 PM - Seeking Alpha

5 Biotechs With January FDA Decision Date Catalysts
12/17/2012 4:35:00 AM - Seeking Alpha

Cowen Maintains An Outperform On Hyperion Therapeutics
12/10/2012 9:00:00 AM - Seeking Alpha

Hyperion Sees Volatility On Pending PDUFA And Rising Short Interest
11/16/2012 4:37:00 PM - Seeking Alpha

Hyperion Therapeutics prices IPO at $10.00, below the range
7/26/2012 8:49:37 AM - Renaissance Capital